Past Grant Recipients
Through our annual fund-raising events (See Event Calendar), MWCABC has succeeded in awarding over $3 million in grants to breast cancer research, education programs and organizations. This accomplishment could only have been achieved with the generous support of our community. Our past recipients include:
2023
• NYU Grossman School of Medicine Examining Novel Therapeutic Strategies Against Breast Cancer Brain Metastasis Dr. Eva Hernando PhD
• Ichan School of Medicine Mt Sinai Enhancing Immunotherapeutic Response Of Triple Negative Breast Cancer With A Novel Cancer Breast Cell Inhibitor Dr. Hanna Irie M.D., Ph.D.
• Weill Cornell Medical College Carbon Monoxide based Approach for Metastatic Breast cancer Prevention and Therapy Dr. Nancy Du PhD
2022
• Cold Spring Harbor Laboratory Harnessing Senolytic CAR T Cells for The Treatment of Breast Cancer Dr. Corina Amor, MD, PHD
• Feinstein Institute of Medicine of Northwell Health Identifying Novel Strategies to Predict and Inhibit IRF5- Mediated Breast Cancer Metastasis Dr. Betsy J. Barnes, PhD
• NYU Langone Medical Center Grossman School of Medicine Repurposing Small Molecules Against Rna Polymerase I To Target Metastatic Breast Cancer Dr. C. Theresa Vincent, PhD
Fall 2021
The Call for Research Proposals was resumed Fall 2021 for Cycle 2022-2023 2021
• Memorial Sloan Kettering Cancer Center Seed Grant MSK Young Women with Breast Cancer Program A Comprehensive Multidisciplinary Program for Young Women with Breast Cancer Dr. Mary L. Gemignani, MD, MPH & Dr. Shari Goldfarb, MD
2020
• The call for Proposals was suspended related to COVD Pandemic and the suspension of institutional support services. MWCABC research funds were diverted by board decision to support Outreach Services during this time of crisis.
2019
• NYU Langone & NYU WinthropSylvia Adams, MD & Douglas K. Marks, MD for their project: Defining Biomarkers Predictive of Chemosensitivity in Triple Negative Breast Cancer by Complex Visual Recognition with Deep Learning
• The Icahn School of Medicine at Mount Sinai Poulikos I. Poulikakos, PhD for his project: A Strategy to Overcome Adaptive Drug Resistance in TNBC
• Memorial Sloan Kettering Cancer Center George Plitas MD for his project: Mapping the Human Breast Cancer Tumor Immune Microenvironment
2018
• WeillCornell Medicine Dr. Jason Spector and Kristy Brown PhD "Tissue Engineered, Patient- Specific Bio Mimetic Simulacra For the High- Throughput Analysis of Novel Brest Cancer Therapeutics".
• Cold Spring Harbor Laboratory Dr. Sonam Bhatia "Evaluating Patient- Specific Breast Tumor Organoids to Identify New Therapeutic Targets".
2017
• Memorial Sloan Kettering Cancer Center $95,751.53 to Christopher Klebanoff, MD of Memorial Sloan Kettering Cancer Center to fully fund his project entitled “Development of a Diagnostic Test for the Cancer-Germline Antigen CT83: a Promising Immunotherapy Target for Patients with Triple Negative Breast Cancer.”
• Feinstein Insitute of Medicine of Northwell Health $54,248.47 to Betsy Barnes, Phd of the Feinstein Institute of Medicine at Northwell Health to partially fund her project entitled “Reprogramming Breast Cancer Immunity.”**
• Colombia University Medical Center $50,000.00 to Kevin Kalinsky, MD, MS of Colombia University Medical Center for one year of his two year research project entitled “Monitoring Neo-Adjuvant Chemotherapy in Breast Cancer Patients with Dynamic Tomographic Imaging.”
2016
• Memorial Sloane Kettering Cancer Center A Prospective Surveillance Program for Assessment and Treatment of Breast Cancer Related Lymphedema after Axillary Lymph Node Dissection.
• Stony Brook University Medical Center A Quantum Leap in Breast Imaging-High-Resolution PET with Concurrent MRI
• Northwell (Feinstein Institute for Medical Reserach) Analysis of Circulation Tumor DNA for Early Detection of Metastatic Breast Cancer
• Cold Spring Harbor Laboratory Characterization of BPTF as a Novel Epigenetic Target Drug in Breast Cancer
2015
• Mount Sinai Icahn School of Medicine Project called Clinical Validation of the cyclinD-1 interactions as a Predictor of Response to Tamoxifen Versus Fulvestrant in Premenopausal Patients with ER+Cancer
• North Shore-LIJ Health Systems Project called “High Throughput Screen Looking for Drugs that interfere with Microphage Stimulated Breast Cancer”.
• St. Francis Hospital Project called “Early Detection of Cardiac Toxicity of Chemotherapy in Breast Cancer Patients”.
2014
• Cold Spring Harbor Laboratory Project called "Assessing the Role of IncRNA's in Mammary Tumor Formation, Progression and Metastasis-Towards a New Therapeutic Approach.
• Columbia University Medical Center Project called “Characterizing the Functional Significance of the Highly Prognostic FGD3-SUSD Metagene in Breast Cancer.
• North Shore-LIJ Health Systems Project called “Improving Quality of Life for Older Adults with Breast Cancer: An Outpatient Collaborative Team Model for an Innovative Breast Cancer and Aging Program”.
2013
• NYU Langone Medical Center Project to determine the mechanism by which breast cancer cells lose DNA methylation. The work is designed to allow for the identification of novel breast cancer drug targets.
• Feinstein Institute for Medical Research at North Shore LIJ Pre-clinical studies to test the effectiveness of semapimod in conjunction with paclitaxel on metastatic breast cancer tumors.
• Memorial Sloan Kettering Cancer Center Study to isolate the mechanisms by which neutrophils (a type of white blood cell) are activated to kill cancer cells. This research aims to change the natural history of breast cancer by discovering the unique stimulants that drive neutrophil activation in breast cancer patients.
2012
• Weill Cornell Medical College Support research on a new microfluidic device to isolate circulating tumor cells and identify biomarkers to predict clinical response to chemotherapy drugs in metastatic breast cancer patients. Fund research targeting the tumor micorenvironment using copper depletion as an anti-angiogenesis agent.
• Memorial Sloan-Kettering Cancer Center Support a project examining the mechanism of the SCCRO gene in controlling the tumor and its microenvironment.
2011
• NYU Langone Medical Center Fund a project to impair certain translation requirements of inflammatory and metastatic breast cancers by targeting the protein synthesis machinery, and to develop new drug therapies.
• Research Foundation at Stony Brook University Investigation to target metastatic breast cancer stem cells using the new generation of taxoids.
• Mt. Sinai Medical Center Support a project investigating the combined effect of endocrine disruptors on breast cancer risk.
• Adelphi NY State Breast Cancer Hotline & Support Program Fund breast cancer support groups.
2010
• Memorial Sloan-Kettering Cancer Center Fund research to study how changes in the Stat3 protein and its activating partner, IL-6, affect cancer stem cell behavior.
• North Shore-LIJ Health System Fund research examining mircroRNA profiles in patients with and without BRCA1 or BRCA2 mutations and family history of breast or ovarian cancers.
• Cold Spring Harbor Laboratory Fund research examining the impact of chemotherapy on immune cells.
• Columbia University Medical Center Support development of models creating the genetic alterations found in triple negative breast cancer.
2009
• NYU School of Medicine Fund research to study how tumor site specific radiation therapy with cell growth factor can empower the immune system to fight tumors elsewhere in the body.
• Research Foundation at Stony Brook University Support investigation regarding cancer stem cells and breast cancer metastasis.
• North Shore-LIJ Health System Fund research toward eliminating vomiting with breast cancer chemotherapy. Adelphi NY State Breast Cancer Hotline & Support Program Support educational programming and the hotline.
2008
• Weill Cornell Medical College www.med.cornell.edu/research Fund research that will test a new imaging approach to enhance the specificity of breast MRIs.
• Cold Spring Harbor Laboratory Fund research investigating why some early breast lesions progress to invasive cancer while others remain benign.
• Memorial Sloan-Kettering Cancer Center Fund development of an interactive, web-based, multimedia educational program to address patient expectations about breast reconstruction.
• Montefiore Medical Center www.montefiore.org/services/coe/cancer/breastcancer/ Fund a new initiative that provides a support network and financial assistance to low- income women with breast cancer after they have undergone reconstructive surgery.
2007
• Memorial Sloan-Kettering Cancer Center Fund research targeted at identifying molecular alterations responsible for basal-like breast cancers and developing targeted drug therapy for patients with these highly aggressive tumors.
• Columbia University Medical Center Support research using a new microarray-based method called MSNP to scan cancer cell genomes for patterns of DNA methylation, which may provide new and more informative ways of classifying breast cancers.
2006
• Cold Spring Harbor Laboratory Fund a project looking to discover new genetic treatment targets. Support research regarding the progression of cell mutations into breast cancer.
• North Shore – LIJ Health System Support expansion of genetic counseling activities for women’s cancers.
• Adelphi New York Statewide Breast Cancer Hotline & Support Program Provide individual and family counseling to women diagnosed with breast cancer and assist with funding two educational forums.
2005
• Columbia University Medical Center Assist in funding a project to identify novel genes that increase susceptibility to breast cancer New York University Cancer Institute Help establish a comprehensive breast cancer database that will link clinical information about patients with banked tissue.
2004
• Memorial Sloan-Kettering Cancer Center Support pilot program to study patterns of protein markers to identify high-risk young women and support a project studying the synergistic effect of a new drug (17-AAG) in combination with other chemotherapy drugs in targeting the HER2 protein.
• Adelphi New York Statewide Breast Cancer Hotline and Support Program Support the 2005-2006 Paths to Wellness complementary workshop series for breast cancer survivors Cold Spring Harbor Laboratory Support development of a DNA biopsy for breast cancer to provide more useful prognostic information
2003
• Weill Cornell Breast Cancer Center Assist research to improve current treatment options North Shore-LIJ Health System Foundation Support genetic research on breast cancer progression markers.
2002
• Susan Love MD Breast Cancer Foundation www.susanlovefoundation.org Fund ductal lavage research Adelphi New York Statewide Breast Cancer Hotline and Support Program Breast cancer education and support
2001
• NYU Cancer Institute Rita J. and Stanley H. Kaplan Comprehensive Cancer Center Toward breast cancer vaccine research and the treatment center
2000
• The Sass Foundation for Medical Research www.sassfoundation.org Breast cancer research fellowships Nassau County Girl Scouts www.gsnc.org Breast health education and awareness NY College for Holistic Health, Education & Research www.nycollege.edu Study of complementary therapy after chemotherapy and radiation
1999
• Cold Spring Harbor Laboratory Contribution toward purchase of a DNA microarray machine The Maurer Foundation for Breast Health Education www.maurer-foundation.org Breast cancer health education
1998
• Carol M. Baldwin Breast Cancer Research Fund, Inc. www.findacure.org Support breast cancer research at University Hospital and Medical Center at Stony Brook
1997
• Breast Cancer Research Foundation (Evelyn Lauder Foundation) www.bcrfcure.org Support various breast cancer research efforts
